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1. Introduction 
Nigeria's size is 923,768 sq km, slightly more than twice the size of California in the US. The 
terrain is mixed with southern lowlands merging into central hills and plateaus. There are 
mountains in the southeast, and plains in north. The climate varies with equatorial weather 
in south, tropical in the centre, and arid in north. The lowest point in Nigeria is the Atlantic 
Ocean at 0 m. The highest point is Chappal Waddi at 2,419 m. Nigeria is home to one of 
Africa's most important rivers, the Niger, which enters the country in the northwest and 
flows southward through tropical rain forests and swamps to its delta in the Gulf of Guinea. 
Just over 135 million people live in Nigeria, making it the most populated country in Africa. 
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Nigeria is made up of 36 states. Figure 1 show the map of Nigeria.  Life expectancy is 
around 47 years. Birth rate is on average 5.45 per woman. Literacy rate is just over 68%. 
English is the official language. Hausa, Yoruba, Igbo (Ibo) and Fulani are commonly spoken 
by the major ethnic groups. Nigeria is composed of more than 250 ethnic groups. The most 
populous and politically influential ethnic groups includes: Hausa and Fulani 29%, Yoruba 
21%, Igbo (Ibo) 18%, Ijaw 10%, Kanuri 4%, Ibibio 3.5%, and Tiv 2.5%. Nigeria is a multi-
religious nation. Muslims constitute 50% of the population while Christians constitute 40% 
while 10% practice their indigenous beliefs.  British influence and control over what became 
Nigeria grew through the 19th century. A series of constitutions after World War II granted 
Nigeria greater autonomy and eventually independence came on October 1st, 1960. 
Following nearly 16 years of military rule, a new constitution was adopted in 1999, and a 
peaceful transition to civilian government was completed. The government faces the 
daunting task of reforming a petroleum-based economy, whose revenues have been 
squandered through corruption and mismanagement. In addition, the defusing 
longstanding ethnic and religious tensions are a priority if Nigeria is to build a sound 
foundation for economic growth and political stability. Oil-rich Nigeria, long hobbled by 
political instability, corruption, inadequate infrastructure, high rate of unemployment and 
poor macroeconomic management and suboptimal health infrastructure is undertaking 
some reforms under a new reform-minded administration. Nigeria's former military rulers 
failed to diversify the economy away from its overdependence on the capital-intensive oil 
sector, which provides 20% of GDP and 95% of foreign exchange earnings, and about 65% of 
budgetary revenues. The largely subsistence agricultural sector has failed to keep up with 
rapid population growth. Nigeria is Africa's most populous country - and the country, once 
a large net exporter of food, now must import food. 
Despite being the largest oil producer in Africa and the 12th largest in the world (Energy 
Information Administration, 2007), Nigeria is ranked 158 out of 177 on the United Nations 
Development Programme (UNDP) Human Poverty Index (UNDP, 2007). This poor 
development position has meant that Nigeria is faced with huge challenges in fighting its 
HIV and AIDS epidemic. In Nigeria, an estimated 3.6 percent of the populations are living 
with HIV and AIDS (UNGASS, 2010).  Although HIV prevalence is much lower in Nigeria 
than in other African countries such as South Africa and Zambia, the size of Nigeria’s 
population (around 149 million) means that by the end of 2009, there were 3.3 million 
people living with HIV (UNAIDS,2010). Approximately 220,000 people died from AIDS in 
Nigeria in 2009 (UNAIDS, 2010). With AIDS claiming so many lives, Nigeria’s life 
expectancy has declined significantly. In 1991 the average life expectancy was 54 years for 
women and 53 years for men (WHO, 2008).In 2009 these figures had fallen to 48 for women 
and 46 for men (CIA World Fact book, 2010). The major sources of HIV infection in Nigeria 
include heterosexual transmission, through unsafe blood transfusion and from mother to 
child transmission. Approximately 80-95 percent of HIV infections in Nigeria are a result of 
heterosexual sex (UNGASS, 2010). Factors contributing to this include a lack of information 
about sexual health and HIV, sexual promiscuity, low levels of condom use, and high levels 
of sexually transmitted diseases. Women are particularly more vulnerable to HIV. In 2009 
women accounted for 56 percent of all adults aged 15 and above living with the virus 
(UNGASS, 2010). HIV transmission through unsafe blood and blood products accounts for 
the second largest source of HIV infection in Nigeria (Federal Ministry of Health, 2009).  Not 
all Nigerian hospitals have the technology to effectively screen blood and therefore there is a 
risk of using contaminated blood. Women and children are particularly at risk as a result of 
malaria and pregnancy-related anaemia. The Nigerian Federal Ministry of Health have 
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responded by backing legislation that requires hospitals to only use blood from the National 
Blood Transfusion Service, which has far more advanced blood-screening technology 
(Nigeria Exchange, 2008).  Each year around 57,000 babies are born with HIV (UNGASS, 
2010). It is estimated that 360,000 children are living with HIV in Nigeria, most of who 
became infected from their mothers (UNGASS, 2010). This has increased from 220,000 in 
2007 (UNAIDS, 2008). In Nigeria there is a distinct lack of HIV testing programmes. In 2007, 
just 3 percent of health facilities had HIV testing and counseling services (WHO, UNAIDS & 
UNICEF, 2008) and only 11.7 percent of women and men aged 15-49 had received an HIV 
test and found out the results (UNGASS, 2010). In 2009 there was only one HIV testing and 
counseling facility for approximately every 53,000 Nigerian adults .This is an indication of 
how desperately the Nigerian government needs to scale up HIV testing services. 
Sex is traditionally a very private subject in Nigeria and the discussion of sex with teenagers 
is often seen as inappropriate. Attempts at providing sex education for young people have 
been hampered by religious and cultural objections (Odutolu, 2005). In 2009 only 23 percent 
of schools were providing life skills-based HIV education, and just 25 percent of men and 
women between the ages of 15 and 24 correctly identified ways to prevent sexual 
transmission of HIV and rejected major misconceptions about HIV transmission (UNGASS, 
2010). In some regions of Nigeria girls marry relatively young, often to much older men. In 
North Western Nigeria around half of girls are married by age 15 and four out of five girls 
are married by the time they are 18 (Erulkar and Bello, 2007). Studies have found that those 
who are married at a younger age have less knowledge about HIV and AIDS, and are more 
likely to believe they are low-risk for becoming infected with HIV (Erulkar and Bello, 2007). 
HIV and AIDS education initiatives need to focus on young married women, especially as 
these women are less likely to have access to health information (Odutolu, 2005). In sub-
Saharan Africa (Brenan et al., 2008) and in other parts of the world, (Barnes et al., 1991) it is 
estimated that there are 12 to 13 infected women for every infected man. Biological, cultural 
and socio-economic factors contribute to women’s greater vulnerability to HIV/AIDS. 
Women are four times more at risk of becoming infected with HIV during unprotected 
vaginal intercourse than men. The vagina’s large surface area of susceptible tissue and micro 
trauma during intercourse makes women more physiologically vulnerable (Nyobi et al., 
2008). The synergy between HIV and other sexually transmitted infections (STIs) is another 
biological factor that makes women more vulnerable. Socio economic factors including 
women’s lack of access to education or personal income perpetuate women’s lower status. 
Moreover widespread poverty drives some women into commercial sex work. Cultural 
traditions such as forced marriage, female genital mutilation and older men’s preference for 
younger women all risk factors prevalent in Nigeria contribute to increased female 
vulnerability to HIV (Pieniazek et al., 1991).  
HIV pandemic is one of the most serious health crisis faced by the world today. Sub-Saharan 
Africa remains by far the worst affected region. In 2007, it contained an estimated 68% of 
people living with HIV and 76% of all Acquired Immunodeficiency Syndrome (AIDS) 
deaths (De Cock and Weiss, 2000).  An estimated 33.4 million people were living with 
HIV/AIDS as at 2009 (UNAIDS, 2008). The HIV/AIDS epidemic has already devastated 
Nigeria, with nearly a million people dead and more than two million children orphaned. 
By 2003, the virus had infected approximately 5% of the adult population of about 100 
million people (UNAIDS/WHO, 2005). In 2002, the National Intelligence Council identified 
the five countries expected to bear the heaviest burden of HIV infection in the expanding 
worldwide epidemic: India, China, Nigeria, Ethiopia, and Russia (Eberstadt, 2002). The 
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Fig. 1. Map of Nigeria showing the 36 states 
council predicted that Nigeria and Ethiopia would be especially hard hit, with the number 
of people living with HIV/AIDS in Nigeria projected to balloon to ten to fifteen million by 
2010, or as much as 26 percent of the adult population. Without effective prevention on a 
large scale, Nigeria will experience not only the tragedy of countless lives forever altered 
by the virus, but also untold adverse social and economic effects. In Nigeria the 
prevalence of HIV has increased from 1.8% in 1991 to 3.8% in 1993, 4.5% in 1999, 5.8%, 
5.0% in 2003, 4.4% in 2005 to 4.6% in 2008 (Federal Ministry of Health Nigeria, 2009). 
Nigeria’s population has grown rapidly in recent decades. In 1991 the total population 
was 88.9 million, and projections by the National Population Commission of Nigeria 
estimated that by 2003 the population would rise to 133 million (National Population 
Commission of Nigeria,  1991).The prevalence of HIV in Nigeria may not be as high as it 
is in most countries in Southern part of Africa. The prevalence is however significant 
considering the population of the country. There has been great concern in the 
international community as to whether Nigeria with her sub-optimal health infrastructure 
will be able to manage this pandemic.  
Poverty is a major challenge associated with the increasing prevalence of HIV in Nigeria. 
With her annual income per capita below the average for other low-income countries, 
Nigeria is considered a “poor” nation. The country’s health status indicators also are worse 
than average; Nigeria spends less than average on health. The United Nations Development 
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Programme has ranked Nigeria 152 out of 175 on the Human Development Index, a 
composite measure of income coupled with access to education and health services (United 
Nations Development Programme, 2004). By some estimates, two-thirds of Nigerians live on 
less than US$1 per day. Youth unemployment is a major problem, with estimates ranging 
between 40% and 60% (World Bank, 2004).Poverty—combined with economic vulnerability, 
institutional weaknesses, and socio-cultural complexity—exacerbates the difficulties 
inherent in tackling the Nigerian HIV epidemic and is responsible for the high HIV 
prevalence observed in selected groups; blood donors (commercial remunerated), 
unemployed, long distance truck drivers, abandoned babies, tuberculosis patient and 
unbooked antenatal women. The complexity of the HIV/AIDS epidemic stems from its links 
with all aspects of society and culture.  Social and cultural factors affect not only viral 
transmission, but also the success of prevention strategies and the compassion with which 
people living with the virus are treated. A clear understanding of these factors therefore 
becomes a point of significance for planning the control of the epidemic. Heterosexual 
transmission accounts for as many as 95% of HIV infections in Nigeria, where having 
multiple sexual partners has been a major behavioural factor fuelling the epidemic. Non-
sexual traditional practices—particularly male and female circumcision and the custom of 
creating facial and body markings with shared, non-sterile skin-piercing implements—
expose significant numbers of people to infection as well. The aim of this chapter is to 
present the challenges associated with the management of HIV/AIDS pandemic in Nigeria.  
2. HIV prevalence among Most At Risk Populations (MARPs) 
2.1 HIV among blood donors and challenges of providing safe blood and blood 
products 
Blood transfusions particularly in sub Saharan Africa currently face interesting challenges of 
accessing safe and adequate quantities of blood and blood products. The risk of transfusion 
–transmissible infections including HIV amongst others have provoked a greatly heightened 
emphasis on safety with inescapable implications on complexity and cost of providing a 
transfusion service (Tagny et al., 2008). Blood transfusion continues to be an important route 
of transmission of HIV particularly in developing countries among young children and 
pregnant women following transfusion for malaria associated anaemia and pregnancy-
related complications (Foster and Buvé, 1995). A study undertaken to determine the 
seroprevalence of human immunodeficiency virus infection among 1,500 blood donors 
living in the Niger Delta area of Nigeria has shown a prevalence of 1.0%. The highest 
prevalence occurred among commercial remunerated donors (Ejele et al., 2005).  Similarly a 
study of 33,682 and 1259 blood donors screened in two tertiary hospitals in Nigeria has 
indicated overall HIV seroprevalence rate of 7.66% (Fasola et al.,2008) and 0.71% (Salawu  
and Murainah, 2006) respectively. Studies to investigate the risk of transfusion transmissible 
HIV infection among Malian blood donors have indicated a prevalence of 2.6% (Diarra et al., 
2009) and 4.5% (Tounkara et al., 2009). Undetectable HIV infections in blood banks pose a 
serious threat to public health (Zohoun et al, 2004). In Kenya, blood donations from high 
school students are preferred over adult samples due to lower HIV infection prevalence 
within this population. However a study carried out using stimmunology, an in vitro 
lymphocyte stimulation technique has unveiled a significant number of early, pre-
seroconversion HIV carriers both among adult and teenage Kenyan populations (Mumo et 
al., 2009, Minga et al., 2010). A mathematical model constructed to quantify transfusion risks 
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across 45 sub-Saharan African countries using three components: the risk of a contaminated 
unit entering the blood supply, the risk that the unit will be given to a susceptible patient 
and the risk that receipt of the unit will lead to infection in the recipient. Variables included 
prevalence of infection in donors, extent of blood testing, test sensitivity, and susceptibility 
of recipients. Data from the World Health Organization (WHO) African Region and a 
systematic review of the literature were used to parameterize the model. Data suggest that 
the median overall risks of becoming infected with HIV from a blood transfusion in SSA 
were 1 infection per 1000 units (Jayaraman et al., 2010). A study to determine the prevalence 
of HIV among adolescent donors in Zimbabwe during the period between 2002 and 2003 
has revealed that the prevalence of HIV in 2002 and 2003 were 0.48% and 0.38%, 
respectively. Prevalence was higher among first time and female donors (Mandisodza et al., 
2006). A study to estimate the prevalence of transfusion-transmissible HIV infection in two 
groups of blood donors at Douala city over the period of 1995 -2004 has indicated that the 
prevalence of HIV ranged from 2.2% to 8.12% at the Douala University and 7.89% at the 
blood bank of Laquintinie Hospital (Mogtomo et al.,2009). Remunerated and family 
replacement donors are at more risk of being HIV positive (Batina et al., 2007). Areas with 
high HIV-incidence rates compared to the developed world may benefit from additional 
testing in blood banks and may show more favourable cost-effectiveness ratios.  
2.2 HIV infection and unemployment 
Youth unemployment is a major problem in Nigeria, with estimates ranging between 40% 
and 60% (World Bank, 2004). Poverty—combined with economic vulnerability, institutional 
weaknesses, and socio-cultural complexity—exacerbates the difficulties inherent in tackling 
the Nigerian HIV epidemic. Human immunodeficiency virus (HIV) infection is highly 
endemic in Nigeria, particularly with the prevalence in 2001 at 5.8%. A previous study (Ejele 
at al., 2005) to determine the prevalence of HIV among 868 unemployed individuals in Port 
Harcourt comprising of 373 males and 495 females indicated a sero-prevalence rate of 
(3.19%). HIV seroprevalence was relatively higher among females (3.6%) compared to males 
(2.4%). The highest prevalence was found in the <19 years age group (5.1%) and lowest in 
the 40-49 years age group (2.3%), although the difference was not statistically significant (X2 
= 4.86, p = 0. 09). The highest prevalence occurred among separated subjects (7.7%) 
compared to singles (3.9%) and married subjects  (1.8%).This study indicates a 3.1% 
prevalence of HIV infection among unemployed individuals studied and calls for urgent 
and concerted efforts aimed at promoting behavioural, cultural and social changes that will 
reverse the current trend in the prevalence of HIV among the unemployed. 
2.3 HIV among abandoned babies in Nigeria 
Paediatric HIV infection is fast assuming a serious dimension in developing countries. In 
addition, the early death of mothers creates a large number of orphans and vulnerable 
children, many of whom succumb to AIDS or complications of other infections and 
malnutrition. This trend is eroding gains of child survival efforts of previous decades. 
Disease progression in children who acquire HIV infection from their mothers is more rapid 
in Africa than in developed countries, probably because African children are exposed to 
early and multiple infections. Abandonment of newborn babies dates back to the bible days 
with the story of Moses. In Nigeria, it is a common observation to find babies abandoned in 
the hospital after birth, in gutters and hidden places possibly because the mother tested 
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positive for HIV. The act of child abandonment is greatly influenced by socio-economic 
constraints. In this era of the HIV Pandemic, many of the abandoned babies are feared to be 
babies of HIV sero positive mothers who for fear of stigmatisation, discrimination and the 
burden of caring for an HIV positive child, abandon their babies. HIV infection is endemic 
in Nigeria and is an important cause of infant mortality and morbidity. A previous study 
(Akani et al.,2006)  was undertaken to determine the sero-epidemiology of HIV among One 
hundred and forty (n = 140) consecutively recruited abandoned babies with mean age of 
11.5 ± 24.1 weeks made up to 79 males and 61 females. The babies were referred to the HIV 
screening unit from motherless baby’s homes in Port Harcourt for pre-adoption HIV 
screening within a five years period (1999 – 2003). Babies were screened for HIV using the 
WHO approved immunocomb HIV I & II kits (Organics, Israel) – an enzyme linked 
immunosorbent assay for the quantitative and differential diagnosis of HIV in serum or 
plasma. Initially reactive samples were continued using Genscreen HIV 1 & 2 (p24) antigen 
test (Bro Rad, France). HIV was detected in 19(13.6%) of babies tested. Sero-prevalence was 
highest in babies 9 – 16 weeks (25.0%). Males accounted for the highest infection burden 
(57.9%) compared to (42.1%) for females. Data indicated that the prevalence of HIV declined 
from 12.5% in 1999 to 8.3% in 2000 and increased subsequently to 20% in 2001 but declined 
steadily to 16.1% in 2002 and 14.3% in 2003. HIV-1 accounted for the predominant viral 
subtype among babies sero-positive for HIV (89.5%). Chi square analysis indicates that 
symptom at abandonment was an independent risk factor for HIV infection among 
abandoned babies (χ2 = 40.97; p = 0.0001). This hospital-based study has confirmed a high 
prevalence of HIV among abandoned babies tested and highlights the importance of HIV 
screening for abandoned babies before transfer to foster parents and brings to bare the 
challenge associated with child adoption in Nigeria. Government, non-governmental 
organizations and Faith Based Organizations (FBO’s) should embark on care and support 
programmes by providing young people with knowledge, information and youth-friendly 
health services in a bid to address the issue of child abandonment and HIV infection. The 
findings emphasize the need for capacity building of personnel working in motherless 
babies home to enable them cope with the challenges of the increasing incidence of child 
abandonment and HIV. There is the need to strengthen the family planning services for sero 
positive mothers who do not wish to have more babies. The issue of therapeutic termination 
of pregnancy in HIV-infected mothers in cases of unwanted pregnancies may need to be 
reconsidered.  
2.4 HIV infection and the Nigerian military 
Epidemiologic evidence indicates that throughout the world men and women in the military 
are among the most susceptible subpopulations to sexually transmitted infections (STIs), 
including HIV. In peacetime, STI rates in the military are two to five times higher than in 
comparable civilian populations; during wartime the rates tend to rise (UNAIDS, 1998). 
Conflict situations involving troops, vulnerable populations, and humanitarian workers 
further promote the transmission of HIV. In many African countries, the uniformed services 
report HIV prevalence rates higher than the national averages. In Uganda (27% versus 8.3%) 
(U.S. Bureau of the Census, Population Division, 1998) in South Africa (60% to 70%, 
compared with 20%) (Sarin, 2003), Cameroon (6.2% compared to 2%) (Adebajo et al., 2002), 
Sierra Leone (11% versus 5%) (Lovgren, 2001). Similarly in Malawi, 25% to 50% of army 
officials are already HIV positive (UNAIDS, 2005). Interestingly HIV/ AIDS is becoming the 
leading cause of death in the military and police forces in many settings in sub Saharan 
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Africa, accounting for as much as half of in-service mortality (Noah  and Fidas, 2000). These 
findings have serious consequence on the territorial security. HIV/AIDS has the potential to 
wipe out the capability and experience of military forces when prevalence rates are high and 
prevention and mitigation efforts are ineffective or insufficient. In sub-Saharan Africa, the 
number of states at war or involved in significant lethal conflicts increased from 11 in 1989 
to 22 in 2000 (Bakhireva et al., 2004, Nwokoji et al., 2004). In a survey conducted in Sierra 
Leone recently, Physicians for Human Rights estimated that 215,000 to 257,000 internally 
displaced women and girls experienced rape or other forms of sexual violence in war, as 
well as non-combat situations. This demonstrates the potential for women to be exposed to 
HIV during conflicts (Lovgren, 2001). Although Nigeria has not experienced a national war 
in the past 37 years, limited internal, inter-ethnic, and religious skirmishes have occurred in 
several regions. Moreover, women and children have become victims of forced sex and 
other human rights abuses. Several studies have shown that HIV prevalence among soldiers 
in Africa is elevated, with prevalence rates as high as 60% in the militaries of Angola and the 
Democratic Republic of Congo (Fleming,1988).Many African military forces have infection 
rates as high as five times those of civilian populations (Nwokoji et al., 2004,  Bakhireva et 
al., 2004). It is important to remember that HIV transmission does not end when conflict 
ceases; when infected soldiers return to their communities, they continue to spread the 
virus. In Nigeria, this trend was confirmed by the increased HIV seroprevalence among 
soldiers returning home from a peacekeeping mission (Lovgren S, 2001). Peacekeeping 
operations by Nigerian soldiers in Liberia, Sierra Leone, Côte d’Ivoire, the former 
Yugoslavia, and Somalia at various times have produced other distinct strands of net 
transfer of infection from these countries to Nigeria. The lifestyle of peacekeeping officers is 
characterized by high levels of multiple sexual partners, low condom use, and exposure to 
blood transfusions in the line of duty. After an initial period of secrecy surrounding the 
extent of the HIV/AIDS problem in the military and among returning peacekeeping forces, 
the Nigerian military is addressing the spread of HIV among soldiers (Raufu, 2001).The 
coming out of soldiers living with HIV/AIDS has raised awareness of the impact of 
peacekeeping expeditions on the spread of HIV. It has also helped shape the public policy 
on HIV in Nigeria. The privileged position of the military means that policies made for it set 
standards to which the public HIV/AIDS policy can aspire, such as the introduction of a 
free antiretroviral program for infected soldiers (Raufu, 2002). Nigerian police officers also 
have been involved in peacekeeping operations, mostly within Nigeria but occasionally 
abroad. Their sexual lifestyles are no less risky than those of soldiers (Akinnawo et al., 1995).  
They maintain modest levels of condom use and high rates of STIs, take advantage of 
modern medical treatment, and report good rates of partner notification when infected but 
low rates of notifying their spouses about infection episodes. A previous study by Azuonwu 
et al (Azuonwu et al., 2011) investigated the prevalence of HIV among a total of One 
hundred and fifty military personnel aged between 20 and 55 years in the Niger Delta of 
Nigeria and observed an overall HIV prevalence rate of 14.67%. The HIV prevalence among 
the male was higher than that of the female group (84% versus 16%). There was a negative 
correlation between the CD4 count and HIV infection (r = -0.443, p <0.01). The military 
community is considered a high-risk environment for HIV transmission. There are several 
compelling risk factors that increase the susceptibility of military personnel to HIV infection; 
danger and risk taking are integral parts of the military profession, military personnel tend 
to be young, single, and sexually active, they are highly mobile and stay away from their 
families and home communities for extended periods, they are often influenced by peer 
pressure rather than social convention, they are inclined to feel invincible and involve in 
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high risk sexual behaviour and they have more ready cash than other males where they are 
deployed and hence are surrounded by opportunities for casual and commercial sex. 
2.5 HIV infection among long distance truck drivers  
Truck drivers play an important role in HIV/AIDS transmission in many countries (Pandey 
et al., 2008, Sunmola, 2005). Previous report in Bangladesh and India found HIV prevalence 
of 15.9% and 17.8% respectively among long distance drivers (Gibney et al., 2003, Manjunath 
et al., 2002). Condom use among long distance drivers is low and /or inconsistent 
(Sugihantono et al., 2003). Long distance truck drivers are vulnerable to sexually transmitted 
diseases for several reasons; truckers are always on the move, have little or no access to 
sexual health services, migratory nature of their occupation often disconnect them from 
family and community, truck drivers rarely interact with orthodox medical practitioners 
and instead seek the help of quacks and home remedies to cure Sexually Transmitted 
infections (STIs) and many lack information about STIs and HIV/AIDS and their 
prevention. Previous report (Azuonwu et al., 2010) on a total of one hundred long-distance 
truck drivers in the Niger Delta of Nigerian aged between 21 and 60 years and mean age of 
42.36 ±5.23 years that were screened for the presence of HIV antibodies indicated a 
prevalence of 10%. The prevalence of HIV was significantly higher in the 31-40 years. HIV 1 
was the predominant viral subtype among the subjects (90%) while (10%) had HIV-2. None 
of the HIV-positive subjects had dual HIV 1 and 2 infections. The mean CD4 lymphocyte 
count for subjects positive for HIV was 380 ± 68.0 (range 312 – 448 cells/µl) while CD4 count 
for HIV negative subjects was 780 ± 76 cells/ µl (range 704 - 856 cells/µl. A significant 
negative correlation   was observed between HIV positivity and CD4 count r-0.010 (p = 
0.01). Authors recommended that intensive preventive measures be instituted coupled with 
the implementation of a vigorous enlightenment campaign targeting behavioural change 
from high risk culture among truckers. Efforts are urgently needed to provide access to 
sexual health education, treatment services and HIV testing facilities to reduce their 
vulnerability to HIV infection.   
2.6 HIV infection among tuberculosis – infected Nigerians 
Nigeria, with estimated 259,000 cases of tuberculosis, has the sixth largest population of 
people with tuberculosis (TB) in the world. The arrival of HIV/AIDS has caused a 
secondary tuberculosis epidemic in many African countries. Before the HIV epidemic, the 
incidence rate of new cases of tuberculosis had been estimated at 2 per 1,000. Tuberculosis 
(TB) and human immunodeficiency virus (HIV) have been closely linked since the 
emergence of acquired immunodeficiency syndrome (AIDS). HIV infection has contributed 
to a significant increase in the worldwide incidence of TB (Low and Eng, 2009).  By 
producing a progressive decline in cell-mediated immunity, HIV alters the pathogenesis of 
TB, greatly increasing the risk of developing the disease in co-infected individuals, leading 
to more frequent extrapulmonary involvement and atypical radiographic manifestations. 
Although HIV-related TB is treatable and preventable, incidence rates continue to climb in 
developing nations where HIV infection and TB are endemic and resources are limited. 
Worldwide, TB is the most common opportunistic infection affecting HIV sero-positive 
individuals and it is the most common cause of death in patients with AIDS (API consensus 
expert committee, 2006). The prevalence of HIV infection among TB patients in several 
African countries ranges from 20% to 60%.1 The World Health Organization (WHO) 
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estimates that about 8 million new cases of TB and nearly 2 million deaths from the disease 
occur each year and approximately 10 million people are estimated to be co-infected with TB 
and HIV, and over 90% of these dually infected individuals reside in developing nations. In 
some areas of sub-Saharan Africa, the rates of co-infection exceed 1,000 per 100,000 
populations (Yusuph, 2005). Worldwide, a similar change has occurred in some developed 
countries. The HIV epidemic has increased the global TB burden and focused attention on 
the need to strengthen links between TB and HIV/AIDS program. In response to these 
health emergencies, the WHO has developed an expanded strategy aimed at reducing the 
burden of HIV-related TB infection through close collaboration between TB and HIV/AIDS 
programmes. Infection with HIV is the most well known risk factor for the development of 
TB. Because of the prevalence of TB amongst HIV-infected patients the joint statement by 
the American Thoracic Society, Centres for Disease Control and Prevention, and Infectious 
Diseases Society of America recommends that all patients with TB undergo testing for HIV 
infection after counselling (Blumberg et al., 2003). A recent study (Erhabor et al., 2010) 
investigated the prevalence of HIV infection among 120 patients diagnosed with 
microbiologically proven TB. Subjects were Nigerians aged 18 to 54 years with a mean age 
of 39.5 years (standard deviation 6.75). Of the 120 TB patients tested (25%) were positive for 
HIV infection. HIV-1 was the predominant viral subtype. HIV prevalence was significantly 
higher in subjects in the 38-47 and 28-37 years age groups. The mean CD4 lymphocyte count of 
the HIV-infected TB subjects was significantly lower (195 ± 40.5 cells/μL) compared to the 
non-HIV infected (288 ± 35.25 cells/μL p = 0.01). This finding is in agreement with previous 
reports among 59 patients with pulmonary TB studied in Kampala, Uganda (De Cock et al., 
1992) in which two-thirds of the patients were HIV sero-positive. Similarly in Sagamu, Nigeria 
Daniel and colleagues (Daniel et al., 2004) observed a 14.9% HIV prevalence amongst their 
cohort of TB infected patients. Of patients with confirmed pulmonary TB in Zambia, 49% were 
positive for HIV (Elliott et al., 1990). Studies among TB patients in Kenya (Barnes et al., 1991) 
observed 40.7% prevalence while nearly 40% of the smear-positive TB patients in Tanzania 
were attributable to HIV (Cantwell et al 1994). However, out of 13,269 patients diagnosed with 
TB in the Netherlands who were then tested for HIV between 1993 to 2001, 542 were HIV 
positive (4.1%) (Haar et al., 2006). Among 184 newly diagnosed TB patients tested for HIV in 
Singapore, 15 (8.2%) was seropositive (Eriki et al., 1991). 
2.7 Challenges of mother – to child transmission of HIV among unbooked antenatal 
patriuents 
Mother-to-child transmission (MTCT) of HIV represents an especially tragic dimension of 
the burden of HIV/AIDS, particularly in resource-constrained settings, where fragile and 
poorly funded health care systems hamper care and prevention efforts. The global HIV 
epidemic continues to expand, with an estimated five million people becoming infected each 
year. Over the decades, the epidemic, once dominated by infected males, has become 
progressively feminized. In sub-Saharan Africa, where about two-thirds of the global 
disease burden resides, 57% of adults living with HIV are women (UNAIDS, 2004). As more 
women contract the virus, the number of children infected from their mothers has been 
growing. Worldwide, an estimated 640,000 children acquired HIV in 2004 alone (UNAIDS, 
2004), with more than 90% of the infections occurring through mother-to-child transmission. 
MTCT has become a critical children’s health problem in Africa, contributing to severe 
morbidity and significant mortality and undermining the impact of programs that had 
significantly reduced child mortality in previous decades. Women can transmit HIV to their 
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babies in utero, during birth, and through breastfeeding. Without preventive interventions, 
approximately 25% to 40% of infants born to HIV-positive mothers will contract the virus. In 
the developed world with lower HIV prevalence rates, mother-to-child transmission has 
dropped to less than 2% with the implementation of universal  Voluntary Counselling and 
Testing ( VCT), ARV prophylaxis, elective caesarean section, and the avoidance of 
breastfeeding (Mofenson, 2003). Unfortunately, in Nigeria and other countries with poor 
health systems, particularly with poor maternal and child health programs, this 
transmission route continues to cause great concern. The key entry point to PMTCT 
programs is the VCT offered to pregnant women. The experiences of PMTCT programs in 
Nigeria and other African nations demonstrate that much of their success is determined by 
the proportion of women, who agree to be tested for HIV, return to obtain their test results, 
and accept the ARV prophylaxis, which is often a single dose of nevirapine. The 
infrastructure, capacity building, and training are required to maximize the “uptake” of 
VCT, as well as the development of clinically proven ARV prophylaxis protocols. ARV 
prophylaxis significantly reduces the rate of mother-to-child transmission of HIV. This 
consists of single or double ARVs during the last trimester of pregnancy or at delivery with 
a goal of lowering viral load to decrease the risk of transmission. Trials of various PMTCT 
protocols have been conducted in the developing world; yet viral drug resistance remains a 
problem (Mofenson et al., 1999). Although the current use of single dose nevirapine to HIV-
infected pregnant women does significantly reduce mother-to-child transmission, it also 
leads to the development of nevirapine resistance in 12% to 40% of women (Eshleman et al., 
2001). The development of drug resistance in either the mother or infant compromises ARV 
provision since nevirapine is often used in first-line regimens for adults and infants in 
developing country programs (Lallement, 2005). To date, the use of various short courses of 
ARVs given during the last trimester of pregnancy reduce levels of viral load and 
significantly lower the risk of in utero and intrapartum infection. HIV transmission through 
breast milk, however, continues to be a major obstacle for PMTCT efforts, particularly in 
Africa, where strong cultural and economic factors favour breast milk feeding rather than 
expensive breast milk substitutes. Furthermore, employment of safe breast milk substitutes 
is complicated by the fact that many HIV-infected women lack access to clean water and 
sanitation. Organized preventive screening programs for antenatal care were first 
introduced in Western Europe in the twentieth century with the hope that routine antenatal 
care would contribute to a reduction in maternal and infant mortality rates. Figures on 
maternal mortality in the developed world show that the risk of death as a result of 
pregnancy and child birth is approximately 1 in 7000 compared with 1 in 23 for women 
living in parts of Africa where antenatal care is poor or nonexistent (Carroli et al., 2001).  
Most children living with HIV in Nigeria acquire the infection through mother-to-child 
transmission (MTCT), which can occur during pregnancy, labour, delivery, or breastfeeding. 
In the absence of any intervention, the risk of such transmission is 15%–30% in non-
breastfeeding populations. Breastfeeding by an infected mother increases the risk by 5%–
20% to a total of 20%–45% (de Cock et al., 2000). The risk of MTCT can be reduced to less 
than 2% by interventions that include antiretroviral prophylaxis given to women during 
pregnancy and labour and to the infant in the first weeks of life, during elective caesarean 
delivery (prior to the onset of labour and rupture of membranes), and avoidance of 
breastfeeding (European collaborative study, 2005). With these interventions, new HIV 
infections in children are becoming increasingly rare in many parts of the world, 
particularly in high-income countries. In many resource-constrained settings, elective 
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caesarean delivery is seldom feasible (Stanton and Holtz 2006), and it is often neither 
acceptable nor safe for mothers to refrain from breastfeeding. However, recent guidelines 
from the World Health Organization (World Health Organization, 2010) recommend that 
mothers known to be HIV-infected (and whose infants are HIV-uninfected or of unknown 
HIV status) should exclusively breastfeed their infants for the first six months of life, 
introducing appropriate complementary foods after that. Breastfeeding should then be 
stopped only when a nutritionally adequate and safe diet without breast milk can be 
provided. In these settings, efforts to prevent HIV infection in infants initially focused on 
reducing MTCT around the time of labour and delivery. The unknown HIV status of these 
unbooked women presenting to clinic for the first time in the third trimester of pregnancy 
poses a risk not only to the patient and her baby, but also to the staff caring for them in the 
peripartum period. A recent study (Akani et al., 2010) was undertaken to determine the 
seroprevalence of HIV infection among unbooked pregnant women in the Niger Delta of 
Nigeria. One hundred and eighteen consecutively recruited unbooked subjects presenting to 
the isolation ward at the University of Port Harcourt Teaching Hospital were screened for 
HIV. Among the 118 subjects studied, 30 (25.4%) were positive for HIV. HIV-1 was the 
predominant viral strain. Gestational age of subjects at presentation was 28–40 weeks and 
mean age was 35.04 ± 8.06 years. The majority of subjects were primigravidas 66 (55.9%), 
while 52 (44.1%) were multigravidas. The prevalence of HIV was significantly higher among 
unbooked pregnant women with less formal education: 14 (11.9%) compared with 9 (7.6%), 
5 (4.2%), and 2 (1.7%) for those with primary, secondary, and tertiary education, respectively 
(P = 0.01). Among the occupational groups, the prevalence of HIV was significantly higher 
among traders 14 (11.9%) than in career women 5 (4.2%, P = 0.04). Multigravid women were 
more susceptible to HIV infection 17 (14.4%) than primigravid women. Perinatal mortality 
and emergency caesarean section was high among unbooked pregnant women. These 
findings are very pertinent to health care delivery, because this pool of unbooked patients 
may not be benefiting from the Prevention of Maternal to Child Transmission program, thus 
increasing the paediatric HIV burden in our environment.   
3. Challenges of HIV sero- discordance and HIV serostatus disclosure 
The disclosure of HIV serostatus is a difficult emotional task creating opportunity for both 
support and rejection (Yashioka and Schustack, 2001). Barriers to disclosure include fear of 
accusation of infidelity, abandonment, discrimination and violence (Medley et al., 2004. 
Stigmatizing belief about AIDS and the associated fear of discrimination can influence 
decision to disclose ones HIV serostatus (Chesney and Smith, 1999). A considerable body of 
evidence has associated the act of disclosing personal trauma-related information with 
improved physiological health and that it can lead to support that facilitates initiation of and 
adherence to treatment (Chandra et al., 2003, Klitzman et al.,2004).The dilemma of choosing 
to disclose personal information is somewhat of a cruel paradox (Harber, 1992 ).Often 
people long to share a trauma or secret with another, yet they fear the possible rejection or 
alienation by the listener (Silver et al., 1990). A previous study (Akani et al., 2006) in the 
Niger Delta of Nigeria evaluated the rate, patterns and barriers to HIV serostatus disclosure. 
A pre-tested interviewer-administered questionnaire from 187 HIV infected people residing 
in a resource-limited setting in the Niger Delta of Nigeria was analysed. Of the 187 HIV 
seropositive patients studied, 144 (77.0%) had disclosed their HIV-serostatus while 43 
(23.0%) had not. Results showed that the patients had disclosed their HIV-serostatus to: 
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parents (22.3%), siblings (9.7%), pastors (27.8%), friends (6.3%), family members (10.4%) and 
sexual partners (23.6%) (p = 0.004). Females were more likely (59.7%) to disclose their HIV 
serostatus compared with males (40.3%) (p = 0.003). Mothers were twice as likely (65.6%) to 
be confided in compared with fathers. Barriers to HIV serostatus disclosure included fear of 
stigmatization, victimization, fear of confidants spreading the news of their serostatus and 
fear of accusation of infidelity and abandonment (p = 0.002). Married respondents were 
more likely to disclose their status. Better-educated respondents with tertiary education 
were more likely to disclose their HIV-serostatus. Expectation of economic, spiritual, 
emotional and social support was the major reason for disclosure. The ratio of disclosure to 
non-disclosure among patients with non-formal education was (2.6:1.0), primary education 
(2.3:1.0), secondary education (3.3:1.0) and tertiary education (10.0:1.0). Disclosure of HIV 
serostatus can foster economic social and economic support. There is need for the re-
intensification of interventional measure that combines provider, patients and community 
education particularly in the aspect of anti-stigma campaign, partner notification and skill 
building to facilitate appropriate HIV serostatus disclosure.  
4. Reproductive health challenges associated with HIV – infection in Nigeria 
Availability and use of antiretroviral drugs has changed the landscape of HIV/AIDS 
bringing about a change in the perception of HIV from an incurable deadly disease to a 
chronic manageable illness. As effective HIV treatments become more widespread, HIV-
infected individuals are living longer and healthier lives. Many HIV-affected couples (sero-
discordant and sero-concordant) are considering options for safer reproduction. A large 
body of evidence suggests that reproductive technologies can help HIV-affected couples to 
safely conceive with minimal risk of HIV transmission to their partner and baby. However, 
for most couples particularly in low income countries in sub Saharan Africa, such 
technologies are both neither geographically nor economically accessible (Matthews and 
Mukherjee, 2009). With HIV now considered to be a chronic manageable disease, attention is 
shifting to offering and improving quality of life particularly by the provision of 
reproductive health options/care to men and women living with HIV-1. Many HIV-infected 
men and women are now expressing their desire to father or mother a child. Assisted 
reproductive technologies, including intrauterine insemination (IUI), in vitro fertilisation 
(IVF) and intracytoplasmatic sperm injection (ICSI) in combination with semen washing 
have been used to decrease the risk of HIV -1 transmission in HIV-1-infected discordant 
couples with an HIV-1-infected man (van et al., 2009) . Previous report indicates that in HIV-
positive men taking HAART, seminal viral load is decreased but not eliminated and 
fertilization should be achieved through sperm washing to offer maximum protection for 
the uninfected female. Pregnant HIV-positive women on antiretroviral medication have a 
reduced risk of transmitting the virus, but should still be counselled about the possibility to 
further limit the chances of infecting their infant through elective Caesarean section 
(Semprini et al., 2004, Semprini et al., 2004b, Barreiro et al.,2007, Matthews et al., 2010) . HIV 
sero-discordant couples with strong desire for childbearing have a dilemma of risking HIV 
infection or infecting their spouse. Some risk transmission of HIV infection to reproduce. 
Over two-thirds of 104 couple wanting to procreate surveyed reported unprotected sex with 
their partner in the past 6 months. Most respondents, regardless of serostatus, said that viral 
load testing and awareness of post-exposure prevention had no effect on their condom use 
(van der Straten et al., 2000). A study to assess the reproductive health concerns among 195 
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persons living with HIV/AIDS in the Niger Delta of Nigeria  Akani et al (in press) showed 
that 111 (56.9 %) indicated their desire to have children. Single subjects were more inclined 
to having children (66.6%) compared to married (53.4%) p= .03. Persons with no formal 
education are about twice as likely to have children (66.7%) compared to persons educated 
to tertiary education level (37, 0%) (p=.01). Knowledge about reproductive health options 
available to reduce risk of infecting their partners and or baby was poor. There is the need to 
support the sexual and reproductive rights of HIV-infected individuals, offer additional 
training to HIV counsellors on evidence-based best and affordable practices regarding 
reproductive health issues, develop policies that support the availability and accessibility to 
relevant reproductive and sexual health services.  
5. Challenges of management of occupational exposure to HIV and 
availability of post exposure prophylaxis 
HIV transmission in health care settings occurs when workers are stuck with needles or 
sharp instruments contaminated with HIV-infected blood or, less frequently, when workers 
are exposed to infected blood through an open cut or a mucous membrane, such as the eyes 
or nasal passages (Campbell, 2004). Patients in African settings may be more likely to be 
infected with HIV. This predisposes health care workers to HIV infection particularly in the 
absence of proper universal precautions. In developed countries, post-exposure prophylaxis 
is part of most health care policies. Post-exposure prophylaxis—a short course of triple-drug 
ART provided to prevent possible HIV infection has yet to be broadly institutionalized in 
Nigeria’s health care facilities. It is hoped that with the increased availability of ARVs, this 
may be feasible in the near future. Sharp injuries and other exposure to patient’s blood carry 
a risk of transmission of blood borne infections including HIV. Despite the long-standing 
recommendations in the developed world that Health Care Workers exposed to infected 
blood and blood product be offered post exposure prophylaxis, they remain unavailable to 
healthcare workers in most resource-limited settings in Sub-Saharan Africa. Also there is 
absence of established occupational health policy and policy for minimising the risk and 
management of percutaneous and mucosal exposure to high risk patient’s blood and body 
fluids. A previous study (Erhabor et al, 2007) was carried out to demonstrate the 
epidemiology and risk of occupational exposure to HIV, HBV and HCV among health care 
workers (HCWs) and highlight areas where greater training is required. The study 
population included 13 health care workers; 5 males (38.5%) and 8 females (61.5%), mean 
age 34.15 +/- 6.8 years including 3 doctors (23.1%), 2 laboratory scientist (15.4%), 1 
laboratory technician (7.7%), 6 medical students (46.2%) and 1 trainee laboratory assistant 
(7.7%). The care and follow-up provided to the health care workers in a 500 -bed tertiary 
health hospital in the Niger Delta of Nigeria who had percutaneous exposure to patient's 
blood between June 2002 and June 2005 were analyzed. All exposed health care workers 
were evaluated and offered follow up counselling. Five millilitres of blood from each of the 
HCWs and the source patients were screened by immmuno-enzymatic testing for HIV, 
HBV, and HCV. Exposures were concentrated in few areas of the hospital; paediatrics 
(46.2%); surgery (15.4%); obstetrics and gynaecology (7.7%) and laboratory unit (30.8%) (p = 
0.05). Risk of exposure was significantly higher among females (61.5%) compared to males 
(38.5%) (p = 0.001). All exposed HCWs were seen and offered post exposure prophylaxis 
within 24 hours of exposure. All the exposed health care workers were sero-negative to HIV, 
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HBsAg and anti-HCV at exposure. The source patients were known in all cases. Evidence of 
HIV was present in 5 (38.5%); 1 (7.7%) had HBV while none had HCV infection. Of all the 
HCWs who completed the follow-up, only 1(7.7%) confirmed case of HBV sero-conversion 
occurred in a HCW who was not previously vaccinated against HBV but who received post 
exposure HBV vaccination. Exposure rate was significantly higher among house officers 7 
(53.9%) followed by registrars 3 (23.1%) and laboratory scientist 3 (23.1) (p = 0.01). There is 
need to urgently address the issue of occupational exposure in Nigeria by the formulation of 
occupational health policy in Nigeria as well as provision of training on universal 
precaution, phlebotomy, modifying procedures that have high risk, developing institutional 
policy for handling of sharps and post-exposure management of healthcare workers as well 
as the provision of protective post exposure prophylaxis for all exposed HCWs. 
6. Challenges of availability of affordable laboratory-monitoring tests and 
trained manpower required for the implementation of HIV therapy 
Few laboratories in resource-constrained countries can afford to perform laboratory-
monitoring tests required for the implementation of HIV therapy. Flow cytometric 
techniques are expensive and require a significant infrastructure to perform. In addition, the 
measurement of quantities of virus in the blood—known as viral load—is an important 
clinical parameter to evaluate the severity of disease and to monitor the efficacy of therapy. 
These expensive laboratory tests require complex technologies not previously used in much 
of the developing world. Scientists are devising new methodologies that they hope will be 
as sensitive as existing methodologies yet more cost effective. The laboratory infrastructure 
is the most expensive and specialized part of any institutional framework for HIV/AIDS 
cares (Stephenson, 2002). In Nigeria, policymakers and decision makers have tended to view 
laboratories in the narrow context of HIV screening. At the onset of the ART program no 
laboratory in the country had the full capacity needed to monitor treatment response and 
toxicity properly. Only a handful of institutions had the capacity to perform CD4+ counts, a 
necessary test for decision-making in HIV therapy. The federal government program 
provided the training and technical capacity for CD4+ tests to be performed in the 25 
treatment centres using a manual microscopic technique. This technology is labour 
intensive, and one laboratory scientist cannot reliably perform more than 10 tests a day. This 
pace cannot accommodate the expansion of ART in these centres and in other centres that 
would rely on them for laboratory support. Through a generous donation from MTN 
Nigeria, a telecommunications company, APIN was able to equip two federal treatment 
centres—at University College Hospital and Jos University Teaching Hospital—with flow-
cytometry–based instruments (Imade et al., 2005), which allow technicians to process more 
than 100 CD4+ tests daily. The instruments cut the cost of the tests four- to fivefold. All 
Harvard PEPFAR program sites are now equipped with these instruments. Many other 
programs in Nigeria, particularly the other PEPFAR programs, have opted for that 
investment as well. Similarly, when the ART program started in Nigeria, only one centre 
had the capacity to perform viral load tests routinely; these tests are used to measure the 
virus level in the blood of infected individuals and thereby allow clinicians to assess 
treatment efficacy. This centre, the Nigerian Institute of Medical Research, had been 
upgraded and equipped by a grant from the Ford Foundation. APIN, a project based at the 
Harvard School of Public Health (HSPH) and sponsored by the Bill & Melinda Gates 
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Foundation, has significantly affected the level of infrastructures available in its four target 
states of Borno, Lagos, Oyo, and Plateau. All APIN sites now routinely perform HIV viral 
load tests with technical assistance and/or equipment provided by HSPH. When HSPH 
became a PEPFAR implementation partner, it further expanded the capacity of its 
collaborating centres. HSPH has provided training and retraining of health professional and 
laboratory personnel and helped upgrade or establish six laboratories for HIV and STI 
services. In addition few sites have facilities to perform infant diagnostics using polymerase 
chain reaction (PCR), the only technique capable of diagnosing HIV infection in infants. In 
addition, most sites have been involved in projects in collaboration with HSPH to conduct 
surveillance studies of the HIV strains circulating in Nigeria and of the drug resistance 
levels in various patient populations. In a previous study in the Niger Delta of Nigeria 
(Erhabor et al., 2006) investigated the relevance of absolute lymphocyte count as a surrogate 
marker for CD4 lymphocyte count as a criterion for initiating HAART in HIV-infected 
Nigerians. A total of 100 consecutive recruited HIV-infected, previously antiretroviral naive 
persons and 30 HIV-negative individuals blood samples were run for absolute lymphocyte 
and CD4 lymphocyte counts and results were compared by a model of linear regression 
analysis. An overall modest correlation was observed between absolute lymphocyte count 
and CD4 lymphocyte (r = 0.51) and at CD4 lymphocyte threshold relevant for clinical 
management of HIV-infected; <200, 200-350 and >350 cells/microL (r = 0.41, 0.30 and 0.21) 
respectively. Mean absolute lymphocyte count of 1.60 +/- 0.77 x 10(9)/L, 1.88 +/- 1.11 x 
10(9)/L and 2.04 +/- 0.54 x 10(9)/L was equivalent respectively to CD4 of <200, 200-350 and 
>350 cells/microL. This study indicated a modest correlation between absolute and CD4 
lymphocyte counts of HIV-infected Nigerians and at CD4 lymphocyte count threshold 
significant for clinical management of HIV-infected. Absolute lymphocyte count can become 
a minimal inexpensive alternative to CD4 lymphocyte count in conjunction with WHO 
staging and clinical status of patient in determining the optimal time to initiate therapy 
particularly in resource limited settings where other expensive methods of CD4 
enumeration are unavailable. The infrastructure for the diagnosis of HIV and monitoring of 
patients on antiretroviral therapy in Nigerians is still sub-optimal and the capacity to 
monitor patients on ARV therapy is inadequate. These diagnostic limitations have hindered 
the effective monitoring of patients on antiretroviral therapy. There is need to improve the 
facilities for HIV diagnosis and treatment monitoring as well as manpower development of 
biomedical scientist to effectively carry out these specialized diagnostic services. 
7. Challenges of deciding the optimal time to start antiretroviral treatment 
Highly active antiretroviral therapy (HAART) has changed the landscape of HIV- related 
care in the developed world with marked reduction in mortality and morbidity (Cameron et 
al., 1998).
 
This possibility however is beyond the reach of a vast majority of HIV-infected in 
sub Saharan Africa. Following the development of HAART, many physicians were quite 
aggressive in treating patients at virtually any stage of this human retroviral disease. 
 
Increasing concern related to drug toxicities, pill burden, cost and ability of patients to 
adhere to strict and complicated regimens, have complicated the decision-making process 
for physicians and patients alike (Volberding,  2000). 
 
Despite promised price-reduction and 
increased availability of generic drugs in some countries, cost remains a major factor in 
deciding when to start therapy. Early intervention suggested that a higher proportion of 
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patients achieved a viral load of < 500 cells/μl if started on HAART at a CD4+ count of >500 
cells/μl and >350 cells/μl rather than at < 200 cells/μl (Meibohm et al., 2000,   Moore et al., 
2000). Long-term clinical outcomes data however are not available to fully endorse this 
approach. The British HIV association recommends that therapy be initiated once CD4+ cell 
count falls to 350 cells/μl (British HIV Association (BHIVA), 2000). The argument for a 
conservative approach in the initiation of HAART is that most regimen are difficult to 
tolerate, non- adherence leads to the development of resistance, thus limiting future 
treatment options (Molla et al., 1996, d’ Arminio Monforte et al., 2000) and that considerable 
reconstitution of the immune system seems possible even in patients initiating HAART at a 
low CD4+ cell count (Miller et al., 1999). Increasing concerns related to cost, drug toxicity, 
pill burden, tolerability ability of patient to adhere to strict and complicated regimen and 
emergence of drug resistance has complicated the decision making process of the optimal 
time to initiate  antiretroviral therapy in Nigeria. A previous study (Ejele et al.,2004) aimed 
at determining if there is any immunological advantage in initiating HAART at a pre-
therapeutic CD4 count of > 350cells/μl rather than at 200-350 or < 200 cells/μl investigated 
one hundred HIV-infected previously antiretroviral- naive individuals grouped under 3 
CD4+ lymphocyte count thresholds; < 200, 200 – 350 and > 350 cells/μl who were 
randomized to take HAART of stavudine (40mg) lamivudine (150mg) and nevirapine 
(200mg) orally twice daily. CD4 lymphocyte count was determined serially every 8 weeks 
for an observation period of 48 weeks. CD4 lymphocyte count responses were compared 
statistically based on pre-therapeutic CD4 lymphocyte counts. The overall increase in CD4 
lymphocyte count irrespective of baseline CD4 count was 122 cells/μl (p < 0.01). CD4 
lymphocyte count response to 48 weeks HAART was significantly higher in patients 
initiating HAART at a pre-therapeutic CD4 count of <200 cells/μl (163 cells/μl) compared to 
118 and 50 cells/μl respectively for those initiating at 200 – 350 and > 350 cells/μl 
respectively. HIV-related morbidity of 3% was found among subjects who initiated HAART 
with a pre-therapeutic CD4 count of < 200 cells/μl. Steven -Johnson syndrome was the 
commonest adverse clinical event observed occurring in 15% of subjects. This study 
indicates that there is no long-term advantage in terms of CD4+ lymphocyte response in 
initiating HAART at a pre-therapeutic CD4 count of > 350 cells/μl rather than at 200 – 350 
cells/μl. This present study appears to support postponing the initiation of therapy in some 
patients until the CD4+ count approaches 200 cells/μl particularly in sub-Saharan Africa 
where drug accessibility and affordability constitutes a major challenge.  
8. Challenges of adherence, compliance, drug resistance and universal 
access to antiretroviral treatment  
With the widespread use of antiretrovirals particularly in the developed world, there has 
been a transformed perception of HIV/AIDS from a fatal incurable disease to a manageable 
chronic illness (Palella et al., 1998) .However access to ART remains limited, especially in 
developing countries where paradoxically a significant number of HIV-infected live but 
with only an insignificant 28% of the 7.1 million in need of treatment having access 
(WHO/UNAIDS/UNICEF 2007). Antiretroviral treatment (ARV) was introduced in Nigeria 
in the early 1990s; they were only available to those who paid for them. As the cost of the 
drugs was very high at this time and the overwhelming majority of Nigerians were living on 
less than $2 a day, only the wealthy minority were able to afford the treatment. In 2002 the 
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Nigerian government started an ambitious antiretroviral treatment programme, which 
aimed to supply 10,000 adults and 5,000 children with antiretroviral drugs within one year. 
An initial $3.5 million worth of ARVs were to be imported from India and delivered at a 
subsidized monthly cost of $7 per person (Odutolu et al., 2006). The programme was 
announced as Africa’s largest antiretroviral treatment programme. By 2004 the programme 
had suffered a major setback as too many patients were being recruited without a big 
enough supply of drugs to hand out. This resulted in an expanding waiting list and not 
enough drugs to supply the high demand. The patients who had already started the 
treatment then had to wait for up to three months for more drugs, which can not only 
reverse the progress the drugs have already made, but can also increase the risk of HIV 
becoming resistant to the ARVs. Eventually, another $3.8 million worth of drugs were 
ordered and the programme resumed. Resources needed to provide sufficient treatment and 
care for those living with HIV in Nigeria are seriously lacking. A study of health care 
providers found many had not received sufficient training on HIV prevention and treatment 
and many of the health facilities had a shortage of medications, equipment and materials 
(Physicians for Human Rights, 2006). The government's National HIV/AIDS Strategic 
Framework for 2005 to 2009 set out to provide ARVs to 80 percent of adults and children 
with advanced HIV infection and to 80 percent of HIV-positive pregnant women, all by 
2010 (WHO, UNAIDS, UNICEF,2007). However, only 31 percent of people who needed 
treatment for advanced HIV infection received it in 2009. According to the latest WHO 
guidelines (2010), which advise starting treatment earlier, HIV treatment coverage is only 
21% (WHO, UNAIDS, UNICEF, 2010). As a result of this slow progress the treatment 
goals were set back to 2015 in the revised framework (2010 to 2015) (NACA, 2009).  It has 
been estimated that the Nigerian government are contributing an insignificant 5 percent 
of the funds for the antiretroviral treatment programmes (HERFON, 2007). The majority 
of the funding comes from development partners. The main donors are PEPFAR (the 
President's Emergency Plan for AIDS Relief), the Global Fund and the World Bank. In 
2002, the World Bank loaned US$90.3 million to Nigeria to support the 5-year HIV/AIDS 
Programme Development Project (HERFON, 2007). In May 2007 it was announced that 
the World Bank were to allocate a further US$50 million loan for the programme (World 
Bank, 2008).  In 2008 PEPFAR provided approximately US$448 million to Nigeria for 
HIV/AIDS prevention, treatment and care, (PEPFAR, 2008) the third highest amount out 
of PEPFAR’s 15 focus countries. In the same vein, the Global Fund in 2008 disbursed 
US$95 million in funds for Nigeria to expand treatment, prevention, and prevention of 
mother-to-child transmission programmes (Global fund 2009). Even the availability of 
financial resources has not brought the number of patients on ART to the level desired 
particularly in some settings in Africa.  
For example the Global fund has put forward US$1.9 billion in order to scale-up access to 
ART (UNAIDS 2006). In some settings in Africa, the cost of antiretrovirals does not seem to 
be the most important constraint of access to ART, as many of the drugs are supplied free of 
cost to eligible patients through combined efforts by countries and bilateral and 
multilateral partners. Mozambique, a country with one of the highest HIV/AIDS burden, 
only 14% of those in need received ART by the end of 2006 (WHO/UNAIDS/UNICEF 
2007). Mozambique  spent less than 30% of the donor funds earmarked  for the health 
ministry (Nemes et al., 2006).This poor absorptive capacity of the public institutions in 
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most countries in Africa shows that there are other factors; health- systems level barriers 
(insufficient human  resources and judicious use of donor funds) and population –level 
barriers (lack of information about ART, stigmatization and discrimination) may prevent 
or restrict access to ART. 
Antiretroviral treatment causes improvement in the immunologic status and reduction in 
the viral load (Erb et al., 2000) thus reducing the incidence of hospitalization and mortality ( 
Paterson et al., 2000) .Treatment effectiveness however requires a high level of adherence to 
medication regimens (Vanhove et al., 1996).Missing of even a few doses of antiretroviral 
medication can lead to drug resistant strains of HIV (Bangsberg et al., 2000).A previous 
study (Erhabor et al., 2009) to investigate the short-term effect of highly active antiretroviral 
therapy on the CD4 lymphocyte count of HIV-infected Nigerians at the Haematology 
Department of the University of Port Harcourt Teaching Hospital involving 70 HIV-infected 
subjects placed on highly active antiretroviral therapy and thirty HIV-infected yet to start 
therapy due to unaffordability were monitored as controls. CD4 lymphocyte count was 
determined at baseline for subjects and controls. Subjects were placed on HAART for 12 
weeks while controls that were yet to start therapy were monitored as controls. CD4 
lymphocyte count was repeated after 12 weeks and the differences compared statistically. 
We observed that subjects and control patients did not differ significantly in their CD4 
lymphocyte count at baseline (p > 0.05), but after 12 weeks HAART in subjects, there was a 
mean increase in CD4 count of (39 cells/μl) in subjects, while untreated controls showed a 
mean decline of (12 cells/μl) p < 0.05. There was a statistically significant variation in the 
therapy dependent increases in CD4 count of HAART treated subjects based on pre-
therapeutic baseline CD4 count (χ2 = 180.39, p < 0.05). The HAART dependent increase in 
CD4 counts was higher in younger subjects 19-28 years (31 cells/μl) compared to older 
subjects 49-58 years (21 cells/μl) (p = 0.01). Similarly CD4 response was found higher in 
females compared to males (p = 0.01). Low adherence has been associated with detectable 
viral load (>500 viral RNA copies/ml of plasma (Ruthbun et al., 2005)   and possible cross 
resistance to other antiretrovirals of the same class (Tchetgen et al., 2001). A previous study 
(Nwauche et al., 2006) to evaluate the factors militating against adherence to antiretroviral 
therapy among 187 HIV-infected persons on a combination therapy of two-nucleoside 
analogue; stavudine and lamivudine and one non-nucleoside nevirapine in the Niger Delta 
of Nigeria indicated an adherence rate of 49.2%.Factors associated with non-adherence 
included; cost of antiretrovirals, educational status of subjects, medication adverse effects, 
occupational factors and high pill burden of prescribed regimen. There is need for universal 
access to antiretroviral treatment .Cost constraint remains a major limiting factor on 
adherence particularly in resource-limited settings (Muko et al., 2004). National government 
particularly those in sub Saharan Africa have prolonged reluctance to provide the best 
possible treatment citing numerous concerns ranging from cost to the ability of patients to 
adhere to complex life-long treatment. However South Africa a country with more than 5 
million citizens living with HIV has proved the pundits wrong. The prices of antiretrovirals 
having precipitously plummeted by more than 95% as a result of the South African 
government developing the political will to take on board the challenge of universal access. 
This strategic and humanitarian obligation has resulted in an increase in adherence to a high 
level of more than 90%.The world health organization must remain resolute on the initiative 
of universal access to antiretroviral treatment particularly in developing countries where 
paradoxically the greatest HIV disease burden exist but with an insignificant number having 
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access. There is an urgent need for universal access and sustainability of antiretroviral 
therapy particularly in resource-limited settings. There is need for supervised medication 
delivery. Efforts should be made towards simplifying the therapeutic regimen to reduce the 
bill burden and substitution with treatment combination and strategies that minimise 
negative adverse effects, coupled with the re-intensification of patient education and 
counselling. 
9. Conclusion 
Nigeria is the most populous nation in Africa Nigeria is the most populous nation in Africa 
and is home is home to more than 130 million people. These individuals belong to more 
than 350 ethnic and linguistic groups, and their country is ranked among the 25 poorest in 
the world. As many as six million people are already infected with the virus. HIV 
prevalence rates in some states are as high as 12 percent. At least two million children have 
been orphaned by AIDS. Health facilities in Nigeria are suboptimal. Nigeria faces many 
daunting challenges in dealing with its HIV/AIDS epidemic.  
Public education must play a key role in the success of prevention programs and increase in 
the uptake of HIV testing. Behavioural change programs must encourage individuals to 
reduce their risk of HIV acquisition. The stigmatization and discrimination that have 
typified societal responses must be dealt with promptly, as they compromise the 
effectiveness of prevention programs. The early involvement and support of the 
government in the HIV/AIDS campaign can set the necessary groundwork for a continuing 
strong leadership that will be critical for initiating and sustaining an effective nationwide 
prevention program. Stigmatization and discrimination against PLWHAs are common in 
Nigeria. Often both Christian and Muslim religious leaders view immoral behaviour as the 
cause of the HIV/AIDS epidemic. PLWHAs often lose their jobs or are denied health care 
services because of the ignorance and fear surrounding the disease. There is need for 
increased national campaigns and more visible and vocal societies and support groups for 
people infected with or affected by HIV as well as education of the public about HIV/AIDS 
in a bid to dispelling myths and giving the disease a human face. 
New methods to detect antibodies to HIV are needed for diagnosis, and although the simple 
rapid test and the enzyme-linked immunosorbent assay formats have been improved, they 
remain expensive for Nigerian patients. Furthermore, voluntary counselling and testing 
(VCT) programs are still based in urban centres, where they remain inaccessible to many 
Nigerians. Clinical management of HIV infection requires the regular measurement of CD4+ 
lymphocytes in the blood. Flow cytometric techniques are expensive and require a 
significant infrastructure to perform. In addition, the measurement of quantities of virus in 
the blood—known as viral load—is an important clinical parameter to evaluate the 
severity of disease and to monitor the efficacy of therapy. These expensive laboratory tests 
require complex technologies not previously used in much of the developing world. 
Scientists are devising new methodologies that they hope will be as sensitive as existing 
methodologies yet more cost effective. To accommodate these new and critical diagnostic 
clinical tools, Nigerian institutions will need ongoing training, capacity building, and 
infrastructure development. These requisites will grow even more acute as the country 
scales up its ART program. 
Healthcare workers are at risk of acquiring HIV infection occupationally through 
percutaneous or mucosal exposure to contaminated blood and body fluids. There is need to 
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urgently address the issue of formulation of occupational health policy in Nigeria as well as 
provision of training on universal precaution, phlebotomy, modifying procedures that have 
high risk, developing institutional policy for handling of sharps and post-exposure 
management of healthcare workers, provision of HIV post-exposure prophylaxis for 
exposed healthcare workers. 
Blood transfusion continues to be an important route of transmission of HIV particularly in 
Nigeria among young children and pregnant women following transfusion for malaria 
associated anaemia and pregnancy-related complications. Nigeria faces several enduring 
challenges; chronic blood shortages, high prevalence of transfusion-transmissible infections, 
absence of functional national blood transfusion service, recruitment and retention of 
voluntary non –remunerated donors. Blood safety remains an issue of major concern in 
transfusion practice in Nigeria where national blood transfusion services and policies, 
appropriate infrastructure, trained personnel and financial resources are inadequate to 
support the running of a voluntary non-remunerated donor transfusion service. This is 
further aggravated by the predominance of family replacement and commercially 
remunerated blood donors, rather than regular benevolent, non-remunerated donors who 
give blood as a result of altruism. We advocate that commercial remunerated donation of 
blood be discouraged. There is need for unlimited supply of highly sensitive HIV test kits 
for the testing of donors. Political will and open-mindedness to innovative ways to improve 
supply and safety of blood are essential to promote more evidence-based approaches to 
blood transfusion practice in Nigeria. 
The development and widespread use of antiretrovirals in the developed world has brought 
about a transformed perception of HIV/AIDS from a fatal incurable disease to a chronic 
manageable illness. There is an urgent need for universal access and sustainability of 
antiretroviral therapy particularly in Nigeria. There is need for supervised medication 
delivery. Efforts should be made towards simplifying the therapeutic regimens to reduce 
the pill burden and substitution with treatment combination and strategies that minimize 
negative adverse effects coupled with the re-intensification of patient’s education and 
counselling. 
There is concern in the developed world about the ability of Nigeria to effectively manage 
her HIV epidemic particularly in the midst of her sub-optimal health infrastructure 
including widespread poverty and a large and sexually active youthful population. The 
most effective interventions has to be multi-sectoral, with a high-level government 
commitment to tackle the problem, policy changes resulting from an awareness of the 
impact of HIV/AIDS on society, and the development of communications and media 
efforts, health interventions targeting high-risk populations, laboratory and field research, 
and scientific training. Without effective multi-sectoral intervention on a large scale, Nigeria 
is likely to experience not only the tragedy of countless lives forever altered by the virus, but 
also untold adverse social and economic effects.  
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